Sentences with phrase «on clinical application»

This practice - oriented four day program focuses on clinical application of the Crucible Approach to sexual desire and intimacy problems, and couples therapy in general.

Content focuses on clinical application and conducting treatment.

The course work covers the essential concepts of psychodynamic psychotherapy with an emphasis on clinical application.

Ms. Woods teaches professional training programs in MBCT, leads mindfulness - based professional training retreats and has presented on the clinical application of mindfulness at numerous conferences.

The Training Program offers a 4 - semester sequence of coursework that moves the student from theory to treatment, with increasing emphasis on clinical application.

Our programs focus on clinical application to help you understand the concepts you need to be successful.

If you are looking to study Nutrition, Herbal Medicine, Homeopathy or Acupuncture in an atmosphere of academic excellence, with a focus on clinical application, you have come to the right place.

The Third International Congress on Responsible Stem Cell Research, scheduled for 25 - 28 April, was to focus on clinical applications of adult and reprogrammed stem cells.

The paper has split scientists, with consensus on the need for a moratorium on clinical applications but disagreement about whether to support basic research on editing genes in human sperm, eggs, or embryos.

In conjunction with IMNE, the Endocrine Society presents the Diabetes Masters Series, a highly sought, interactive regional meeting series that is in its seventh year of providing healthcare professionals with current evidence on the clinical applications of available and emerging treatment options for patients with type 2 diabetes mellitus (T2DM).

Accelerate the development of novel diagnostics and therapeutics for the treatment of lymphoid cancers by fostering a cutting - edge multi-disciplinary research environment with a focus on clinical applications.

He has developed an in - depth course series for professionals on the clinical applications of essential oils.

Dr. Hyman is doing a special six - part webinar series on clinical applications of functional medicine to brain and mood disorders.

SUMMARY * Innovative and result oriented research scientist with a strong multidisciplinary background (Molecular Biology, Cellular Biology and Cancer Biology) with a focus on clinical applications.

Part 2 of this webinar series focuses on clinical applications of working with adolescents who are transgender or gender nonconforming.

Not exact matches

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Given the clinical trial results underpinning a new drug application for Kite Pharma's lead candidate, which the Food and Drug Administration is currently reviewing, I'd say there's a solid chance Gilead can squeeze out a return on its investment.

In this randomized, double - blind clinical trial, virgin coconut oil was the clear winner: «among pediatric patients with mild to moderate AD, topical application of virgin coconut oil for eight weeks was superior to that of mineral oil based on clinical (SCORAD) and instrumental (TEWL, skin capacitance) assessments.»

Read on for technical insights and market information on key usage applications and opportunities for these dairy ingredients in three growing categories that are highly dependent on high - quality protein sources: sports nutrition, infant and early child nutrition and clinical nutrition.

Science Translational Medicine: Peer - reviewed Research, Perspectives, Reviews, and Commentary focusing on basic, translational, and clinical research and its application;

At Mayo, some immunologists work on basic research and others lean more toward the clinical applications of immunotherapy.

Apart from its research applications, aCGH is well on its way to becoming a standard clinical diagnostic tool.

The article went on to proclaim this «the first clinical application of iPS cells» and said the results were being presented at a conference in New York.

The case study on cystic fibrosis is intended to as a model for clinical application.

The UK also offers a favorable funding and regulatory climate, says Minger, whose lab works on the therapeutic and clinical applications of stem cell research.

The interaction of these disciplines shaped my scientific perspective and focused my career on understanding and engineering organs for clinical applications.

To strengthen its clinical research profile, Dresden has created a strategic plan, to be funded by the German Research Ministry (BMBF), that focuses on three aspects of clinical research: tissue engineering and development of physical and molecular medical technologies for clinical application; therapeutic strategies after cell and tissue damage; and diagnosis and therapy of malignant diseases.

Though clinical applications are still years away, the scientists say the two - pronged approach to research on the protein's effects broadens its potential usefulness in diagnostics and therapies.

The fact that only just over a third of men and women reporting a problem meeting all three criteria had sought professional help in the last year, suggests that a huge number of people experiencing dysfunction are not receiving help — around 1.2 million in the UK and 5.8 million in the U.S. Overall, this study helps demonstrate how the DSM - 5 diagnostic criteria impose a focus on clinically significant symptoms, posing promising applications in both clinical and research contexts.

The technique, which is published online this week in the Proceedings of the National Academy of Sciences, has broad applications for clinical care and research that rely on accurate analysis of blood and other biofluids.

This combination of job responsibilities allows her to focus on methods to bridge the gap between research and clinical application of biomarker findings.

Her current research focuses on developing clinical applications for imaging flow cytometry, with special attention to transcription factor pathways.

«This step in the UK will stimulate debate on legal regulation of germline gene editing in clinical settings,» says Tetsuya Ishii, a bioethicist at Hokkaido University in Sapporo, Japan, who notes that some countries do not explicitly prohibit reproductive applications.

Supporting focused research based on priorities of immediate clinical relevance to Australians, and in key areas such as Indigenous health, rural and remote health, and application of genomics to personalised medicine

An international group of 11 organizations with genetics expertise has issued a policy statement on germline genome editing in humans, which recommends against genome editing that culminates in human pregnancy; supports publicly funded, in vitro research into its potential clinical applications; and outlines scientific and societal steps necessary before implementation of such clinical applications is considered.

Torroni thinks the results auger well for eventual clinical applications of T - 5 magnesium, whose mechanical properties are comparable to titanium, even in mandibular fractures, where stress on bone is particularly high.

The team of biomedical engineers — Rao and Kannan — focus on assessing numerous applications of these probes, including standard biopsy analysis and pushing the technology into clinical practice through the development of a point - of - care cancer detection device.

It is still too early to think about its clinical application, but the work reveals a new genetic target on which to look for new possible therapeutic strategies.

The foundation envisions the retreat as an opportunity for the postdocs to share research perspectives and for RCT to share views on the interaction of basic biomedical research with the development of clinical applications.

If a peer - reviewed paper bears out the news story, «It's one more step on the path to potential clinical application,» says bioethicist Jeffrey Kahn of Johns Hopkins University in Baltimore, Maryland, who served on a committee convened by the U.S. National Academy of Sciences (NAS) and the National Academy of Medicine in Washington, D.C., to address gene editing.

He cautions that the study is years from a clinical application, but says, «most studies so far have concentrated on bacterial factors.

Clinical applications Part of the reason dolphins are expert divers is because they can collapse their alveoli, the little sacks on the lungs that monitor air flow, and then open them up again, «but humans can't do that,» Fahlman said.

IRDiRC Recognized Resources is a quality indicator, based on a specific set of criteria, that was created to highlight key resources which, if used more broadly, would accelerate the pace of translating discoveries into clinical applications.

The Center provides them with resources for both blue - sky and de-risking work: blue - sky research follows up on promising but uncertain scientific leads; while de-risking research is necessary to move a promising biomedical discovery through all the rigorous tests required for clinical applications.

Dr. Gore's research program is focused on the development and application of imaging, especially magnetic resonance imaging and spectroscopy techniques, in clinical and basic science.

The initiative symbolizes the mission of the CMI, which is to develop multidisciplinary teams focused on translating basic scientific research into clinical and societal applications, with the overall goal of improving animal and human health.

Thirdly, the current, almost universal dependency of organoid culture on the use of Matrigel as a replacement for the function of the extracellular basement matrix in providing structural support and survival signals to the epithelial cells hampers clinical application, considering its origin from a mouse sarcoma cell line, its poorly defined composition and its mechanical rigidity after plating.

Sunday, September 25 2:15 - 3:00 pm — The godfather of iPSCs, Nobel Prize - winner Shinya Yamanaka presents the opening keynote address on recent progress made in iPSC research and future clinical applications of the technology.

«Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease» by name of Hyslop et al. will be published in Nature at 18:00 UK time on Wednesday 8th June, which is also when the embargo will lift.